Editorial: Glycoconjugates in vaccines and immunotherapeutics

dc.contributor.author	Shivatare, Sachin	en_US
dc.contributor.author	Sanjiv, Kumar	en_US
dc.contributor.author	KIKKERI, RAGHAVENDRA	en_US
dc.contributor.author	Adamo, Roberto	en_US
dc.date.accessioned	2022-08-30T08:49:27Z
dc.date.available	2022-08-30T08:49:27Z
dc.date.issued	2022-08	en_US
dc.identifier.citation	Frontiers in Immunology, 13.	en_US
dc.identifier.issn	1664-3224	en_US
dc.identifier.uri	https://doi.org/10.3389/fimmu.2022.941474	en_US
dc.identifier.uri	http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/7343
dc.description.abstract	NIL	en_US
dc.language.iso	en	en_US
dc.publisher	Frontiers Media S.A.	en_US
dc.subject	Glycoconjugate	en_US
dc.subject	Svaccines	en_US
dc.subject	Infectious Diseases	en_US
dc.subject	Cancer	en_US
dc.subject	Adjuvants	en_US
dc.subject	2022-AUG-WEEK5	en_US
dc.subject	TOC-AUG-2022	en_US
dc.subject	2022	en_US
dc.title	Editorial: Glycoconjugates in vaccines and immunotherapeutics	en_US
dc.type	Editorial Material	en_US
dc.contributor.department	Dept. of Chemistry	en_US
dc.identifier.sourcetitle	Frontiers in Immunology	en_US
dc.publication.originofpublisher	Foreign	en_US